14
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Serum hepatocyte growth factor levels in patients with chronic renal disease - effect of GFR and pathogenesis

, , , , , & show all
Pages 615-619 | Published online: 08 Jul 2009

  • Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizo S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3.
  • Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Gohda E, Daikuhara Y, Kitamura N. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-73.
  • Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culture. Proc Natl Acad Sci USA 1986; 83: 6489-93.
  • Goto T, Sugimura K, Harimoto K, Kasai S, Kim T, Kishimoto T. Hepatocyte growth factor in glycerol induced acute renal failure. Nephron 1997; 77: 440-4.
  • Matsumoto K, Mizuno S, Nakamura T. Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics. Curr Opin Nephrol Hypertens 2000; 9: 395-402.
  • Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncol 1992; 3: 27-54.
  • Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993; 268: 21212-7.
  • Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404-10.
  • Vargas GA, Hoeflich A, Jehle PM. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 2000; 57: 1426-36.
  • Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993; 265: F61-9.
  • Miller SB, Martin DR, Kissane J, Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ishemic renal injury in rats. Am J Physiol 1994; 266: F129-34.
  • Sugimura K, Goto T, Kasai S, Tsuchida K, Takemoto Y, Yamagami S, Kishimoto T. The activation of serum hepatocyte growth factor in acute renal failure. Nephron 1997; 76: 364-5.
  • Libella C, Rampino T, Esposito C, Fornoni A, Semeraro L, Canton AD. Stimulation of hepatocyte growth factor in human acute renal failure. Nephron 1998; 80: 41-5.
  • Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, Dworkin LD. Up-regulation of hepatocyte growth factor receptor an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int 1999; 55: 442-53.
  • Liu Y, Rajur K, Tolbert E, Dworkin LD. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 2000; 58: 2028-43.
  • Chang H, Nagao T, Ichikawa N, Kawamoto T, Nakamura T, Kurokawa K, Asano S, Katoh T. Blood hepatocyte growth factor levels in chronic renal failure patients. Nephron 1994; 67: 497-8.
  • Sugimura K, Kim T, Goto T, Kasai S, Takemoto Y, Matsuda J, Yoshimoto M, Yamagami S, Kishimoto T. Serum hepatocyte growth factor levels in patients with chronic renal failure. Nephron 1995; 70: 324-8.
  • Lohr JW, Lee TP, Farooqui M, Mookerjee BK. Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease. J Med 2000; 31: 131-41.
  • Nishida M, Kawakatsu H, Ishiwari K, Tamai M, Sawada T, Nishimura M, Yoshimura M. Serum hepatocyte growth factor levels in patients with renal diseases. Am J Nephrol 1999; 19: 509-12.
  • Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol 2000; 54: 203-9.
  • Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998; 58: 585-92.
  • Christensen AB, Groth S. Determination of 99Tc-DTPA clearance by a single plasma sample method. Clin Physiol 1986; 6: 579-88.
  • Wang SN, Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial flbrosis. Am J Physiol 2000; 278: F554-60.
  • Takahashi T, Huynh-Do U, Daniel TO. Renal microvascular assembly and repair: power and promise of molecular definition. Kidney Int 1998; 53: 826-35.
  • Jørgensen PE. Urinary epidermal growth factor. Danish Med Bull 1997; 44: 111-24.
  • Mizuno S, Kuruzawa T, Matsumoto K, MizunoHorikawa Y, Okamoto M, Nakamura T. Hepatocyte growth factor prevents renal flbrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998; 101: 1827-34.
  • Mizuno S, Matsumoto K, Kurosawa T, MizunoHorikawa Y, Nakamura T. Reciprocal balance of hepatocyte growth factor and transforming growth factor-ß1 in renal flbrosis in mice. Kidney Int 2000; 57: 937-48.
  • Sugimura K, Lee C-CR, Kim T, Goto T, Kasai S, Harimoto K, Yamagami S, Kishimoto T. Production of hepatocyte growth factor is increased in chronic renal failure. Nephron 1997; 75: 7-12.
  • Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-53.
  • Kulseng B, Børset M, Espevik T, Sundan A. Elevated hepatocyte growth factor in sera from patients with insulin-dependent diabetes mellitus. Acta Diabetol 1998; 35: 77-80.
  • Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayashi S-I, Nakano N, Katsuya T, Nakata S, Takami S, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun 1998; 242: 238-43.
  • Liu K-X, Kalo Y, Narukawa M, Kim DC, Hanano M, Higuchi O, Nakamura T, Sugiyama Y. Importance of the liver in plasma clearance of hepatocyte growth factor in rats. Am J Physiol 1992; 263: G642-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.